Publication:
Chemerin as a Novel Crevicular Fluid Marker of Patients With Periodontitis and Type 2 Diabetes Mellitus

Simple item page
dc.contributor.authorDogan, Seyma Bozkurt
dc.contributor.authorBalli, UMUT
dc.contributor.authorDede, Figen Ongoz
dc.contributor.authorSertoglu, Erdim
dc.contributor.authorTazegul, Kaan
dc.contributor.institutionauthorBALLI, UMUT
dc.date.accessioned2021-02-01T20:59:23Z
dc.date.available2021-02-01T20:59:23Z
dc.date.issued2016-08-01T00:00:00Z
dc.description.abstractBackground: The objectives of the present study are to: 1) determine whether gingival crevicular fluid (GCF) chemerin is a novel predictive marker for patients with chronic periodontitis (CP) with and without type 2 diabetes mellitus (t2DM); 2) analyze the relationship between chemerin and interleukin (IL)-6 in periodontally healthy individuals and in patients with CP and with and without t2DM; and 3) evaluate the effect of non-surgical periodontal therapy on GCF chemerin levels.
dc.identifier.citationDogan S. B. , Balli U., Dede F. O. , Sertoglu E., Tazegul K., -Chemerin as a Novel Crevicular Fluid Marker of Patients With Periodontitis and Type 2 Diabetes Mellitus-, JOURNAL OF PERIODONTOLOGY, cilt.87, ss.923-933, 2016
dc.identifier.doi10.1902/jop.2016.150657
dc.identifier.scopus84979944197
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28232
dc.identifier.wosWOS:000380843900012
dc.titleChemerin as a Novel Crevicular Fluid Marker of Patients With Periodontitis and Type 2 Diabetes Mellitus
dc.typeArticle
dspace.entity.typePublication
local.avesis.id3999092b-2561-42a9-a66f-9cf9f9782e7d
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication98da5869-ea4b-40c5-873f-9bbd29c50a23
relation.isAuthorOfPublication.latestForDiscovery98da5869-ea4b-40c5-873f-9bbd29c50a23
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files
Collections
Silinecekler